Therapy with a purified plasminogen concentrate in an infant with ligneous conjunctivitis and homozygous plasminogen deficiency

New England Journal of Medicine

Volumn 339, Issue 23, 1998, Pages 1679-1686

  Schott, Dorothee ^a,f   Dempfle, Carl Erik ^a   Beck, Peter ^a   Liermann, Andreas ^a   Mohr Pennert, Anita ^b   Goldner, Michael ^a   Mehlem, Peter ^a   Azuma, Hiroyuki ^d   Schuster, Volker ^e   Mingers, Anne Marie ^e   Schwarz, Hans Peter ^c   Kramer, Michael Dieter ^a   Liesenhoff, Hans ^a   Niessen, Karl Heinz ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Hyland Immuno Div Baxter Hlthcare   (Germany)

^c Hyland Immuno Division   (Austria)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

^e UNIVERSITY OF WÜRZBURG   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; D DIMER; DNA; FIBRIN MONOMER; FIBRINOGEN; PLASMINOGEN; THROMBIN ANTITHROMBIN COMPLEX;

ARTICLE; BLOOD CLOTTING; CASE REPORT; CONJUNCTIVITIS; CONTROLLED STUDY; DRUG HALF LIFE; FIBRINOLYSIS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; INFANT; LASER NEPHELOMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RESTRICTION FRAGMENT; SUBSTITUTION THERAPY; WOUND HEALING;

BLOOD COAGULATION FACTORS; CONJUNCTIVITIS; HALF-LIFE; HOMOZYGOTE; HUMANS; HYDROCEPHALUS; INFANT, NEWBORN; MALE; PEPTIDE FRAGMENTS; PLASMINOGEN; POINT MUTATION; RESPIRATORY SYSTEM; RESTRICTION MAPPING; SEQUENCE ANALYSIS, DNA; VISCOSITY; WOUND HEALING;

EID: 0032480957     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199812033392305     Document Type: Article

References (43)

1. Eagle RC Jr, Brooks JS, Katowitz JA, Weinberg JC, Perry HD. Fibrin as a major constituent of ligneous conjunctivitis. Am J Ophthalmol 1986; 101:493-4.
2. Hidayat AA, Riddle PJ. Ligneous conjunctivitis: a clinicopathologic study of 17 cases. Ophthalmology 1987;94:949-59.
3. Bateman JB, Pettit TH, Isenberg SJ, Simons KB. Ligneous conjunctivitis: an autosomal recessive disorder. J Pediatr Ophthalmol Strabismus 1986;23: 137-40.
4. Chambers JD, Blodi FC, Golden B, McKee AP. Ligneous conjunctivitis. Trans Am Acad Ophthalmol Otolaryngol 1969;73:996-1004.
5. Cooper TJ, Kazdan JJ, Cutz E. Ligneous conjunctivitis with tracheal obstruction: a case report with light and electron microscopy findings. Can J Ophthalmol 1979;14:57-62.
6. Firat T. Ligneous conjunctivitis. Am J Ophthalmol 1974;78:679-88.
7. Francois J, Victoria-Troncoso V. Treatment of ligneous conjunctivitis. Am J Ophthalmol 1968;65:674-8.
8. Marcus DM, Walton D, Donshik P, Choo L, Newman RA, Albert DM. Ligneous conjunctivitis with ear involvement. Arch Ophthalmol 1990;108: 514-9.
9. Scurry J, Planner R, Fortune DW, Lee CS, Rode J. Ligneous (pseudomembranous) inflammation of the female genital tract: a report of two cases. J Reprod Med 1993;38:407-12.
10. Bouisson M. Ophthalmie sur-aigue avec formation de pseudomembranes à la surface de la conjonctive. Ann Ocul 1847;17:100-4.
11. Borel MG. Un nouveau syndrome palpébral. Bull Soc Fr Ophtalmol 1933;46:168-80.
12. Nussgens Z, Roggenkamper P. Ligneous conjunctivitis: ten years follow-up. Ophthalmic Paediatr Genet 1993;14:137-40.
13. Babcock MF, Bedford RF, Berry FA. Ligneous tracheobronchitis: an unusual cause of airway obstruction. Anesthesiology 1987;67:819-21.
14. Schwartz GS, Holland EJ. Induction of ligneous conjunctivitis by conjunctival surgery. Am J Ophthalmol 1995;120:253-4.
15. Diamond JP, Chandna A, Williams C, et al, Tranexamic acid-associated ligneous conjunctivitis with gingival and peritoneal lesions. Br J Ophthalmol 1991;75:753-4.
16. Mingers AM, Heimburger N, Zeitler P, Kreth HW, Schuster V. Homozygous type I plasminogen deficiency. Semin Thromb Hemost 1997; 23:259-69.
17. Schuster V, Mingers AM, Seidenspinner S, Nussgens Z, Pukrop T, Kreth HW. Homozygous mutations in the plasminogen gene of two unrelated girls with ligneous conjunctivitis. Blood 1997;90:958-66.
18. Mingers AM, Heimburger N, Lutz E. Familiärer homozygoter und heterozygoter Typ I-Plasminogenmangel. In: Scharrer I, Schramm W, eds. 25: Hämophilie-Symposium Hamburg 1994. Berlin, Germany: Springer-Verlag, 1996:96-104.
19. Drew AF, Kaufman AH, Kombrinck KW, et al. Ligneous conjunctivitis in plasminogen-deficient mice. Blood 1998;91:1616-24.
20. Kao WW, Kao CW, Kaufman AH, et al. Healing of corneal epithelial defects in plasminogen- and fibrinogen-deficient mice. Invest Ophthalmol Vis Sci 1998;39:502-8.
21. Robbins KC, Summaria L. Human plasminogen and plasmin. Methods Enzymol 1970;19:184-99.
22. Gissler HM, Simon MM, Kramer MD. Enhanced association of plasminogen/plasmin with lesional epidermis of bullous pemphigoid. Br J Dermatol 1992;127:272-7.
23. Schafer BM, Maier K, Eickhoff U, Todd RF, Kramer MD. Plasminogen activation in healing human wounds. Am J Pathol 1994;144:1269-80.
24. Petersen TE, Martzen MR, Ichinose A, Davie EW. Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system. J Biol Chem 1990;265:6104-11.
25. Azuma H, Uno Y, Shigekiyo T, Saito S. Congenital plasminogen deficiency caused by a Ser572 to Pro mutation. Blood 1993;82:475-80.
26. Schuster V, Seidenspinner S, Kreth HW. Detection of a novel mutation in the SRC homology domain 2 (SH2) of Bruton's tyrosine kinase and direct female carrier evaluation in a family with X-linked agammaglobulinemia. Am J Med Genet 1996;63:318-22.
27. Freitag HJ, Becker VU, Thie A, et al. Lys-plasminogen as an adjunct to local intra-arterial fibrinolysis for carotid territory stroke: laboratory and clinical findings. Neuroradiology 1996;38:181-5.
28. Shapiro A, Abe T, Aledort LM, et al. Low risk of viral infection after administration of vapor-heated factor VII concentrate or factor IX complex in first-time recipients of blood components. Transfusion 1995;35:204-8.
29. Forsgren M, Raden B, Israelsson M, Larsson M, Heden LO. Molecular cloning and characterization of a full-length cDNA clone for human plasminogen. FEES Lett 1987;213:254-60.
30. Mirshahi S, Soria J, Nelles I, et al. Plasminogen activators in human corneal fibroblasts: secretion, cellular localization and regulation. Fibrinolysis Proteolysis 1996;10:255-62.
31. Carmeliet P, Moons L, Ploplis V, Plow E, Collen D. Impaired arterial neointima formation in mice with disruption of the plasminogen gene. J Clin Invest 1997;99:200-8.
32. Bugge TH, Kombrinck KW, Flick MJ, Daugherty CC, Danton MJ, Degen JL. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 1996;87:709-19.
33. Cohen SR. Ligneous conjunctivitis: an ophthalmic disease with potentially fatal tracheobronchial obstruction: laryngeal and tracheobronchial features. Ann Otol Rhinol Laryngol 1990;99:509-12.
34. Ploplis VA, Carmeliet P, Vazirzadeh S, et al. Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation 1995;92:2585-93.
35. Tait RC, Walker ID, Conkie JA, Islam SI, McCall F. Isolated familial plasminogen deficiency may not be a risk factor for thrombosis. Thromb Haemost 1996;76:1004-8.
36. Shigekiyo T, Uno Y, Tomonari A, et al. Type I congenital plasminogen deficiency is not a risk factor for thrombosis. Thromb Haemost 1992;67: 189-92.
37. Sartori MT, Patrassi GM, Theodoridis P, Perin A, Pietrogrande F, Girolami A. Heterozygous type I plasminogen deficiency is associated with an increased risk for thrombosis: a statistical analysis in 20 kindreds. Blood Coagul Fibrinolysis 1994;5:889-93.
38. Leebeek FW, Knot EA, Ten Cate JW, Traas DW. Severe thrombotic tendency associated with a type I plasminogen deficiency. Am J Hematol 1989;30:32-5.
39. Dolan G, Greaves M, Cooper P, Preston FE. Thrombovascular disease and familial plasminogen deficiency: a report of three kindreds. Br J Haematol 1988;70:417-21.
40. Girolami A, Marafioti F, Rubertelli M, Cappellato MG. Congenital heterozygous plasminogen deficiency associated with a severe thrombotic tendency. Acta Haematol 1986;75:54-7.
41. Lijnen HR, Carmeliet P, Bouche A, et al. Restoration of thrombolytic potential in plasminogen-deficient mice by bolus administration of plasminogen. Blood 1996;88:870-6.
42. Dempfle CE, Pfitzner SA, Schott D, Niessen KH, Heene DL. Fibrinogen heterogeneity in homozygous plasminogen deficiency type I: further evidence that plasmin is not involved in formation of LMW- and LMW'-fibrinogen. Thromb Haemost 1997;77:879-83.
43. Azuma H, Mima N, Shirakawa M, et al. Molecular pathogenesis of type I congenital plasminogen deficiency: expression of recombinant human mutant plasminogens in mammalian cells. Blood 1997;89:183-90.